advertisement

---

Gugleta K 9

Showing records 1 to 9 | Display all abstracts from Gugleta K

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Chatzimichail E
Drug design, development and therapy 2025; 19: 2519-2531

---

126377 Investigation of Endothelial Cell Density after PreserFlo Implantation Compared to Contralateral Eyes without PreserFlo Implantation - A Retrospective Analysis
Grobshäuser E; Cunha Vaz Martinho A
Klinische Monatsblätter für Augenheilkunde 2025; 242: 392-397

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Christodoulaki E
Drug design, development and therapy 2025; 19: 2519-2531

---

126377 Investigation of Endothelial Cell Density after PreserFlo Implantation Compared to Contralateral Eyes without PreserFlo Implantation - A Retrospective Analysis
Gatzioufas Z
Klinische Monatsblätter für Augenheilkunde 2025; 242: 392-397

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Konstas PAG; Tsiropoulos GN
Drug design, development and therapy 2025; 19: 2519-2531

---

126377 Investigation of Endothelial Cell Density after PreserFlo Implantation Compared to Contralateral Eyes without PreserFlo Implantation - A Retrospective Analysis
Hasler P; Maloca P
Klinische Monatsblätter für Augenheilkunde 2025; 242: 392-397

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Amaxilati E
Drug design, development and therapy 2025; 19: 2519-2531

---

126377 Investigation of Endothelial Cell Density after PreserFlo Implantation Compared to Contralateral Eyes without PreserFlo Implantation - A Retrospective Analysis
Gugleta K
Klinische Monatsblätter für Augenheilkunde 2025; 242: 392-397

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Gugleta K; Gatzioufas Z; Panos GD
Drug design, development and therapy 2025; 19: 2519-2531

---